Officer sold ~$5.88M of Moderna
Scheduled in advanceLoading…
MRNA · NASDAQ · Biotechnology
Biotechnology company based in Cambridge, Massachusetts.
In the last 90 days, no insider of Moderna reported an open-market purchase and 10 open-market sales worth about $49.2M. Members of Congress disclosed 2 trades in its stock. The latest 13F reports cover the quarter ending Jun 30, 2026. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$203.21
Last 12 months
+613.3%
Market value
$81.1B
S&P 500 +15.8% over the same dates. Prices adjusted for splits and dividends.
Bets against the stock: 32.9M shares sold short (8.2% of shares outstanding), −16.0% vs the previous count, 2.5 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Moderna: 1 fund cut or exited a position in the latest 13F filings and 1 member of Congress disclosed sales. 2 of 3 kinds of disclosure lean the same way. This counts filings; it does not say why, or what happens next. How well this has worked
Revenue
$145M
+2.1% vs the same quarter a year earlier
Free cash flow, last 12 months
−$1.24B
This quarter −$563M, a year earlier −$922M
Net cash
$1.13B
Debt $591M, cash $1.72B, at Jun 30, 2026
Net income, last 12 months
−$3.15B
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 31, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
10 sales
$49.2M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$1.94B
−39.9% vs the year before
Net income, fiscal 2025
−$2.82B
A loss for the year
Shares outstanding
399M
As of Jul 24, 2026
In fiscal 2025 the company spent $2M buying back its own shares. Cash actually paid, from its cash-flow statement.
Officer sold ~$5.88M of Moderna
Scheduled in advanceOfficer sold ~$5.81M of Moderna
Scheduled in advanceOfficer plans to sell ~$5.88M of Moderna
Planned, from payPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
A securities lawsuit naming the company as a defendant was filed on Aug 9, 2024 in the U.S. District Court, D. Massachusetts. A filing is an allegation, not a finding.
Wentz v. Moderna, Inc., 1:24-cv-12058Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
Last 12 months, adjusted daily closes
Adjusted close went from $27.54 on Oct 6, 2025 to $203.21 on Oct 5, 2026 (+637.9%). Disclosed activity in the last 12 months: 0 insider purchases, 19 insider sales (17 under pre-arranged plans), 1 Congress purchase, 1 Congress sale, 0 fund reports of opening or adding and 1 fund report of trimming or selling out (13F, quarter-end snapshots).
Short sale volume: 60.5% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 55.0%. FINRA daily files, to Oct 5, 2026.
Fails to deliver: 38K shares (about $5.4M) were not delivered on time for settlement on Sep 14, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
FMR LLC
Schedule 13G: passive · filed Aug 6, 2026 · 51.8M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 25.9M shares
Capital World Investors
Schedule 13G: passive · filed Aug 12, 2026 · 22.3M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.